Education and motivational interviewing to improve COPD patient care
Official title: The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients: A Randomized Controlled Trial
Run by Kahramanmaraş İstiklal University · NCT06733662 · Data updated 2026-11-12
This study is testing whether education and motivational interviewing can help people with COPD stick to their treatment plans and take better care of themselves.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Kahramanmaraş İstiklal University Academic / other |
| Locations | 1 site (Kahramanmaraş) |
| Status | Recruiting |
| Started | August 15, 2024 |
| Main results expected | January 10, 2025 |
| Study ends | February 15, 2025 |
| Registry record updated | December 13, 2024 |
| Trial ID | NCT06733662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with a confirmed diagnosis of COPD for at least six months who are willing to participate and can communicate effectively.
✕Probably not a fit
Patients experiencing exacerbations, those who are uncooperative due to dyspnea, or individuals with malignant or psychiatric illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial aims to assess the impact of education and motivational interviewing on treatment adherence and self-care agency among patients with Chronic Obstructive Pulmonary Disease (COPD). Participants will be divided into intervention and control groups, with the intervention group receiving a single educational session followed by multiple motivational interviewing sessions. Data will be collected before and after the intervention to evaluate changes in adherence and self-care capabilities. The study seeks to provide insights into effective strategies for enhancing patient engagement in their own care.
Why it matters
Potential benefit: If successful, this approach could significantly improve treatment adherence and self-care among COPD patients, leading to better health outcomes.
How similar studies have gone: Previous studies have shown that motivational interviewing can enhance treatment adherence in various chronic conditions, suggesting potential success for this approach in COPD.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed diagnosis of COPD for at least 6 months * Admitted to the chest clinic * No communication problems * Patients who volunteered to participate in the study. Exclusion Criteria: * In the period of exacerbation * Uncooperative due to dyspnea * With a malignant disease * Patients with a confirmed diagnosis of psychiatric illness
Where it's running
-
Kahramanmaraş Istiklal Universty
Kahramanmaraş, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Yasemin SAZAK
- Email: yasemin.sazak@istiklal.edu.tr
- Phone: 541 447 49 44
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.